Abstract:Objective: During the last decade, the management of gastric intestinal metaplasia (GIM) has been addressed by several distinct international evidence-based guidelines. In this review, we aimed to synthesise these guidelines and provide clinicians with a global perspective of the current recommendations for managing patients with GIM, as well as highlight evidence gaps that need to be addressed with future research. Design: We conducted a systematic review of the literature for guidelines and consensus statements published between January 2010 and February 2023 that address the diagnosis and management of GIM. Results: From 426 manuscripts identified, 16 guidelines were assessed. There was consistency across guidelines regarding the purpose of endoscopic surveillance of GIM, which is to identify prevalent neoplastic lesions and stage gastric preneoplastic conditions. The guidelines also agreed that only patients with high-risk GIM phenotypes (eg, corpus-extended GIM, OLGIM stages III/IV, incomplete GIM subtype), persistent refractory Helicobacter pylori infection or first-degree family history of gastric cancer should undergo regular-interval endoscopic surveillance. In contrast, low-risk phenotypes, which comprise most patients with GIM, do not require surveillance. Not all guidelines are aligned on histological staging systems. If surveillance is indicated, most guidelines recommend a 3-year interval, but there is some variability. All guidelines recommend H. pylori eradication as the only non-endoscopic intervention for gastric cancer prevention, while some offer additional recommendations regarding lifestyle modifications. While most guidelines allude to the importance of high-quality endoscopy for endoscopic surveillance, few detail important metrics apart from stating that a systematic gastric biopsy protocol should be followed. Notably, most guidelines comment on the role of endoscopy for gastric cancer screening and detection of gastric precancerous conditions, but with high heterogeneity, limited guidance regarding implementation, and lack of robust evidence. Conclusion: Despite heterogeneous populations and practices, international guidelines are generally aligned on the importance of GIM as a precancerous condition and the need for a risk-stratified approach to endoscopic surveillance, as well as H. pylori eradication when present. There is room for harmonisation of guidelines regarding (1) which populations merit index endoscopic screening for gastric cancer and GIM detection/staging; (2) objective metrics for high-quality endoscopy; (3) consensus on the need for histological staging and (4) non-endoscopic interventions for gastric cancer prevention apart from H. pylori eradication alone. Robust studies, ideally in the form of randomised trials, are needed to bridge the ample evidence gaps that exist.

Global prevalence of gastric intestinal metaplasia: a systematic review and meta-analysis

Interpretation of American Gastroenterological Association Clinical Practice Guidelines on Management of Gastric Intestinal Metaplasia (2019 Edition)

Gastric Microbiota in Gastric Cancer and Precancerous Stages: Mechanisms of Carcinogenesis and Clinical Value

S2334 Risk Factor Prevalence in Gastric Intestinal Metaplasia in a Diverse Urban Population

Risk of gastric cancer among patients with gastric intestinal metaplasia

Gastric intestinal metaplasia: progress and remaining challenges

Endoscopic Surveillance of Gastric Intestinal Metaplasia: A Retrospective Cohort Study

Gastric Intestinal Metaplasia in Children: Natural History and Clinicopathological Correlation

Global Progression Rates of Precursor Lesions for Gastric Cancer: A Systematic Review and Meta-Analysis

The road to a world-unified approach to the management of patients with gastric intestinal metaplasia: a review of current guidelines

IDDF2022-ABS-0213 Gastric Intestinal Metaplasia May Attenuate Reflux Symptoms – Analysis of a Large Observational Prospective Cohort

Gastric intestinal metaplasia regression in United States population: A retrospective longitudinal study

Research Advance of Gastric Dysplasia and Intestinal Metaplasia

Revealing the pathogenesis of gastric intestinal metaplasia based on the mucosoid air-liquid interface

Gastric Cancer and Intestinal Metaplasia: Differential Metabolic Landscapes and New Pathways to Diagnosis

From intestinal metaplasia to gastric cancer: Witnessing the rise of evil over time and space.

Severity of Gastric Intestinal Metaplasia Predicts the Risk of Gastric Cancer: a Prospective Multicentre Cohort Study (GCEP).

Interobserver agreement of estimating the extent of intestinal metaplasia in patients with chronic atrophic gastritis

Genomic and Epigenomic Profiling of High-Risk Intestinal Metaplasia Reveals Molecular Determinants of Progression to Gastric Cancer

Systematic Review and Meta-analysis of TP53, HER2/ERBB2, KRAS, APC, and PIK3CA Genes Expression Pattern in Gastric Cancer

S2290 Prevalence and Characteristics of Precursor Lesions in Patients with Gastric Adenocarcinoma: A Single Tertiary Care Center Analysis